BioVersys

OverviewSuggest Edit

BioVersys is a company that develops drugs and compounds. The company focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. It offers a preclinical candidate against tuberculosis.
TypePrivate
Founded2008
HQBasel, CH
Websitebioversys.com

Locations

BioVersys is headquartered in
Basel, Switzerland

Location Map

Latest Updates

Employees (est.) (Aug 2020)19(+6%)
Cybersecurity ratingCMore

BioVersys Office Locations

BioVersys has an office in Basel
Basel, CH (HQ)
Hochbergerstrasse 60C
Show all (1)

BioVersys Financials and Metrics

Summary Metrics

Founding Date

2008

BioVersys total Funding

$16.7 m

BioVersys latest funding size

$8.87 m

Time since last funding

9 months ago

BioVersys investors

BioVersys's latest funding round in October 2019 was reported to be $8.9 m. In total, BioVersys has raised $16.7 m
Show all financial metrics

BioVersys Cybersecurity Score

Cybersecurity ratingPremium dataset

C

72/100

SecurityScorecard logo

BioVersys Online and Social Media Presence

Embed Graph

BioVersys Frequently Asked Questions

  • When was BioVersys founded?

    BioVersys was founded in 2008.

  • How many employees does BioVersys have?

    BioVersys has 19 employees.

  • Who are BioVersys competitors?

    Competitors of BioVersys include AN2 Therapeutics, Amunix Pharmaceuticals and AbbVie.

  • Where is BioVersys headquarters?

    BioVersys headquarters is located at Hochbergerstrasse 60C, Basel.

  • Where are BioVersys offices?

    BioVersys has an office in Basel.

  • How many offices does BioVersys have?

    BioVersys has 1 office.